Roger Green is joined by KOL Mazen Noureddin to discuss a complex and developing NASH therapeutic landscape and takeaways from an exciting month of meetings. This is the first conversation of a series of deep-dive episodes dedicated to unpacking the 2023 EASL Congress and the 83rd annual American Diabetes Association Scientific Sessions.
Hannes Hagström, Michelle Long, Rachel Zayas, Jeff McIntyre, Michael Betel and Roger Green get together for an in-depth wrap-up session on EASL Congress 2023. In this final conversation the panelists revisit some of the more interesting moments of the meeting before answering a question around what takeaways will reshape the way we think and act moving forward.
Hannes Hagström, Michelle Long, Rachel Zayas, Jeff McIntyre, Michael Betel and Roger Green get together for an in-depth wrap-up session on EASL Congress 2023. In this conversation each panelist revisits the posters and presentations they found compelling. As expected from such a diverse group, the discussion touches on a range of fascinating topics all worth consideration.
Hannes Hagström, Michelle Long, Rachel Zayas, Jeff McIntyre, Michael Betel and Roger Green get together for an in-depth wrap-up session on EASL Congress 2023. In this conversation, the panelists discuss scoring systems used to evaluate NASH.
Hannes Hagström, Michelle Long, Rachel Zayas, Jeff McIntyre, Michael Betel and Roger Green get together for an in-depth wrap-up session on EASL Congress 2023. In this first of four conversations, the panelists share their initial impressions before diving into the implications of the new nomenclature rollout.
Surfing NASH reports on-site coverage from EASL Congress 2023 in Vienna. Ian Rowe, Michael Betel, Jörn Schattenberg and Roger Green get together early in the morning to compare notes and takeaways from an energizing meeting.
In an extra-sode with Arun Sanyal, David Kleiner and Roger Green, the podcast investigates challenges in using ordinal manual histopathology in NASH clinical trials and how AI systems might ameliorate or minimize these challenges.
This conversation covers final thoughts on the anticipations of Ian Rowe, Jörn Schattenberg and Roger Green heading into EASL Congress 2023. The group primarily explores a session on NAFLD clinical aspects which provides practical presentations around tools available now for treating and managing patients with NASH.
This conversation with Ian Rowe, Jörn Schattenberg and Roger Green begins to unpack the rich EASL Congress 2023 program and explore in detail presentations of interest. Specifically, the group dives into anticipations around an abstract session around diagnostics and non-invasive assessment.
This episode comprises three separate sessions as part of the Surfing NASH ongoing coverage of a highly anticipated EASL Congress 2023. The first two discussions feature Ian Rowe, Jörn Schattenberg, Louise Campbell and Roger Green as the group reviews their lists of abstracts to look forward to. Following is an extra-sode on the subject of AI and pathology with guests Arun Sanyal and David Kleiner.
